FDA Real-Time Surveillance Not Practical For All Drugs, CDER’s Safety Surveillance Chief Says

 
• By Derrick Gingery
  
surveillance
FDA official says devoting resources to real-time surveillance of all approved drugs would not be useful. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Drug Safety

More from Pink Sheet